Paradigm Biopharmaceuticals | PAR - Pre Tax Profit

Stock Price
0.23
Daily Change
0.01 2.22%
Monthly
-11.54%
Yearly
-24.59%
Q2 Forecast
0.25

Paradigm Biopharmaceuticals reported -642K in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Avita Medical AUD -11.64M 12.13M Dec/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Pacific Edge NZD -714K 49K Mar/2024
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025